Rare Lymphomas

The past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clin...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Dreyling, Martin (Editor ), Williams, Michael E. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2014.
Edición:1st ed. 2014.
Colección:Hematologic Malignancies,
Temas:
Hematology.
Oncology.
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-642-39590-1
003 DE-He213
005 20220118170241.0
007 cr nn 008mamaa
008 140213s2014 gw | s |||| 0|eng d
020 |a 9783642395901  |9 978-3-642-39590-1 
024 7 |a 10.1007/978-3-642-39590-1  |2 doi 
050 4 |a RC633-647 
072 7 |a MJF  |2 bicssc 
072 7 |a MED038000  |2 bisacsh 
072 7 |a MJF  |2 thema 
082 0 4 |a 616.15  |2 23 
245 1 0 |a Rare Lymphomas  |h [electronic resource] /  |c edited by Martin Dreyling, Michael E. Williams. 
250 |a 1st ed. 2014. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2014. 
300 |a X, 364 p. 80 illus., 70 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Hematologic Malignancies,  |x 2197-9774 
505 0 |a I General:  Pathology -- Cytogenetics -- Molecular Genetics -- Signal Pathways -- II Disease-specific: T-NHL: Acute T-cell leukemia -- Anaplastic lymphoma -- Nasal/NK-cell lymphoma -- Cutaneous T-cell lymphoma -- B-NHL: Adult Burkitt -- Primary Mediastinal Lymphoma -- CNS Lymphoma -- HIV-Associated lymphoma -- Marginal Zone Lymphoma -- MALT -- MCL -- Waldenstroem -- PLL -- Llymphocyte Predominant Hodgkin -- Cutaneous B-cell lymphoma. 
520 |a The past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist.   This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe the histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity. This book will prove an excellent resource for both experienced and inexperienced practitioners. 
650 0 |a Hematology. 
650 0 |a Oncology. 
650 1 4 |a Hematology. 
650 2 4 |a Oncology. 
700 1 |a Dreyling, Martin.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Williams, Michael E.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783642395895 
776 0 8 |i Printed edition:  |z 9783642395918 
776 0 8 |i Printed edition:  |z 9783662507728 
830 0 |a Hematologic Malignancies,  |x 2197-9774 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-642-39590-1  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714) 

Ejemplares similares